14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of LIFE
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Evaluation of aTyr Pharma stock downgraded after the last trading session.
(Updated on Apr 24, 2024)

Sell candidate since Apr 24, 2024 PDF

The aTyr Pharma stock price fell by -1.23% on the last day (Wednesday, 24th Apr 2024) from $1.62 to $1.60. During the last trading day the stock fluctuated 5.10% from a day low at $1.57 to a day high of $1.65. The price has fallen in 8 of the last 10 days and is down by -9.6% for this period. Volume has increased on the last day by 66 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 288 thousand shares were bought and sold for approximately $460.41 thousand.

The stock is at the lower part of a very wide and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at $1.58 will give a strong sell signal and a trend shift may be expected. Given the current horizontal trend, you can expect aTyr Pharma stock with a 90% probability to be traded between $1.56 and $1.99 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

LIFE Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, April 17, 2024, and so far it has risen 0.629%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The aTyr Pharma stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.61 and $1.78. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). aTyr Pharma gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Buy
Special Signal Notification

Double Bottom Formation

Double Bottom Formation A buy signal from a double bottom formation was found on Wednesday, April 17, 2024 and based on theory for this formation the price should go up by 31.23% to $2.10 within 27 trading days since signal was issued (Thursday, April 25, 2024).

Support, Risk & Stop-loss for aTyr Pharma stock

aTyr Pharma finds support from accumulated volume at $1.60 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0800 between high and low, or 5.10%. For the last week, the stock has had daily average volatility of 4.98%.

aTyr Pharma is oversold on RSI14 (24). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (LIFE) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect aTyr Pharma to open at $1.61, and during the day (based on 14 day Average True Range), to move between $1.50 and $1.70, which gives a possible trading interval of +/-$0.0996 (+/-6.23%) up or down from last closing price. If aTyr Pharma takes out the full calculated possible swing range there will be an estimated 12.45% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.60 (0.31%) than the resistance at $1.88 (17.50%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is aTyr Pharma stock A Buy?

aTyr Pharma holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -3.139 Sell Candidate Downgraded

Predicted Opening Price for aTyr Pharma of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
$1.61 ( 0.417%) $1.60

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for LIFE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.69 5.42 %
R2 1.66 3.51 %
R1 1.64 2.33 %
Current price: 1.60
Support S1 1.58 -1.49 %
S2 1.56 -2.67 %
S3 1.53 -4.58 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.97 23.13 %
R2 1.91 19.38 %
R1 1.88 17.50 %
Current price 1.60
Support S1 1.60 -0.313%
S2 1.59 -0.625%
S3 1.55 -3.13%

FAQ

What is the symbol for aTyr Pharma Stock and on which exchange is it traded?
The symbol for aTyr Pharma is LIFE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell aTyr Pharma Stock?
aTyr Pharma holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy aTyr Pharma Stock?
aTyr Pharma Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy aTyr Pharma Stock.

What's the current price of aTyr Pharma Stock?
As of the end of day on the Apr 24, 2024, the price of an aTyr Pharma (LIFE) share was $1.60.

What is the 52-week high and low for aTyr Pharma Stock?
The 52-week high for aTyr Pharma Stock is $2.70 and the 52-week low is $1.08.

What is the market capitalization of aTyr Pharma Stock?
As of the Apr 24, 2024, the market capitalization of aTyr Pharma is 108.4M.

When is the next earnings date for aTyr Pharma?
The upcoming earnings date for aTyr Pharma is May 14, 2024.
Click to get the best stock tips daily for free!

About aTyr Pharma

aTyr Pharma aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and ... LIFE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT